ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion

Also written as “Cetaphil”, “Facial Cleanser” and “Facial cleanser”.

Its studies are mostly in Psoriasis, led by 2 companies.

Drug pageCetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion: every studyAll 7 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Mar 20, 20244 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Galderma Groupits history only20 open or runningphase 4since Mar 20, 2024Mar 20, 2024none ahead
Revision Skincareits history only20 open or runningno phasesince Sep 4, 2020Sep 4, 2020none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of every company. Pick one to see its own:

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 4, 2020First study: no phase study in Fine LinesNew to Revision SkincareRevision Skincare · NCT04545970 · 56 enrolled · United States
  2. Oct 11, 2021No phase study in WrinklesRevision Skincare · NCT05089851 · 29 enrolled · United States
  3. Mar 20, 2024Galderma Group’s first study: phase 4 study in PsoriasisNew to Galderma GroupGalderma Group · NCT06357221 · 46 enrolled · United States
  4. Jan 13, 2026Phase 4 study in Crepey SkinGalderma Group · NCT07398989 · 32 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07398989Crepey Skin · United States4CompletedGalderma GroupMar 25, 202632
NCT06357221Psoriasis · United States4CompletedGalderma GroupJul 18, 202446
NCT05089851Wrinkles · United States–CompletedRevision SkincareJun 3, 202129
NCT04545970Fine Lines · United States–CompletedRevision SkincareMar 11, 202056

How it is read

Names in the registry

  • “Cetaphil”, 2 entries
  • “Facial Cleanser”, 1 entry
  • “Facial cleanser”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.